Represented
Embark Biotech and its shareholders in connection with the sale of Embark Biotech's main program, EMB1, to Novo Nordisk for a consideration of up to EUR 471m in combined cash and potential development, regulatory and commercial milestone payments
Represented
Polaris Private Equity and current and former members of the management of DXC Technology's Eclipse business, Jørgen Jakobsen and René Ebbesen, in connection with a private equity-backed management buy-out of certain assets and liabilities of DXC Technology's Eclipse business in Denmark, Norway and Sweden
Represented the sellers of
EGN Group in connection with the sale of EGN Group to
Gridiron Capital owned
Vistage Worldwide, Inc.
Represented
Blockdaemon in connection with the acquisition of 100% of the shares in
Sepior ApS
Represented the sellers of
Evomove A/S in connection with their sale of Evomove A/S to
Stokke
Represented
Metafy, Inc. in connection with the acquisition of the Danish company
GamerzClass ApS
Represented
Polaris and the minority sellers in connection with the sale of its majority shareholding in Designers Company to
Design Holding
Represented
Kantar in connection with its acquisition of
Blackwood Seven
Represented
Aras Corporation in connection with the combination of
Minerva PLM into Aras’ business through an acquisition of 100 % of the shares in Minerva Group A/S
Represented LI Enterprises Group in the acquisition of
Broen-Lab from Danish private equity fund
Capidea